Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg. (Q34560089)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg. |
scientific article |
Statements
1 reference
Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg. (English)
1 reference
Jaap Verweij
1 reference
Martine Van Glabbeke
1 reference
Ian R Judson
1 reference
Marcus Schlemmer
1 reference
John R Zalcberg
1 reference
Peter Reichardt
1 reference
Michelle Brown
1 reference
EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group
1 reference
Australasian Gastrointestinal Trials Group
1 reference
1 August 2005
1 reference
1 reference
Identifiers
1 reference